NEWS | March 17, 2023

St. Elizabeth Healthcare Invests $250,000 In Sense Neuro Diagnostics

Cincinnati MedTech Startup one of Eight Winners at 2022 Medical Innovation Challenge

CINCINNATI, OH – March 17, 2023 – Medical technology startup Sense Neuro Diagnostics has received $250,000 in  funding from St. Elizabeth Healthcare in Edgewood, Kentucky. The investment will help Sense Neuro Diagnostics as  the company advances clinical trials in its effort to commercialize a non-invasive technology to monitor traumatic  brain injuries. 

Sense Neuro Diagnostics is in the process of testing an innovative, non-invasive technology that can collect 360 data  points in 2.5 seconds to detect brain hemorrhage or stroke type. This technology has the potential to help first  responders, emergency department personnel, neuro ICU teams, and military field hospitals assess and monitor  traumatic brain injuries and assess different stroke types.  

“Innovation is one of our core values and at the root of so much that St. Elizabeth does,” says Sarah Giolando, senior  vice president and chief strategy officer, St. Elizabeth Healthcare. “We are pleased to partner with Sense Neuro  Diagnostics and help advance this novel technology with the goal of ultimately saving more lives in our hospitals and  across Northern Kentucky and Greater Cincinnati.” 

More than 20 sites across the United States, Canada, and India are currently engaged in pivotal trials to evaluate  Sense Neuro Diagnostics’ in-hospital device, and five sites are evaluating its military field device. 

“Our technology has the potential to be a total gamechanger for emergency rooms and hospital staff who treat  people with traumatic brain injuries and stokes every day,” says Geoff Klass, CEO, Sense Neuro Diagnostics. “Sense  Neuro Diagnostics is grateful for this partnership with St. Elizabeth Healthcare and we can’t wait until their talented  medical professionals can apply this technology to their care first-hand.”